Several clinical parameters and
biomarkers have been proposed as prognostic markers for
stroke. However, it has not been clarified whether the risk factors affecting the prognosis of patients with recurrent and first-ever
stroke are similar. In this study, we aimed to explore the relationship between soluble
lectin-like oxidized low-density lipoprotein receptor 1 (sLOX-1) levels and the prediction of the functional outcome in patients with recurrent and first-ever
stroke. A total of 266 patients with recurrent and first-ever
stroke, who underwent follow-up for 3 months, were included in this study. Plasma samples were collected within 24 h after onset. The results showed that
biomarkers for the prognosis of patients with recurrent
stroke were different from that of those with first-ever
stroke. sLOX-1 levels were correlated with modified Rankin Scale scores of patients with recurrent
stroke alone (r = 0.3232, p = 0.001). sLOX-1 levels were also associated with an increased risk of unfavorable outcomes in patients with recurrent
stroke with an adjusted odds ratio of 1.489 (95% confidence interval, 1.204-1.842, p < 0.0001). Combining the risk factors showed greater accuracy for prognosis, yielding a sensitivity of 93.2% and a specificity of 75%, with an area under the curve of 0.916, evaluated by the receiver operating characteristic curve. These findings suggest that the diagnosis and prognosis are different between patients with recurrent
stroke and those with first-ever
stroke, and sLOX-1 level is an independent prognostic marker in patients with recurrent
stroke.